Nehal I Rizk, Heba M Midan, Gouda Kamel Helal, Ahmed I Abulsoud, Shereen Saeid Elshaer, Ahmed A El-Husseiny, Doaa Fathi, Nourhan M Abdelmaksoud, Sherif S Abdel Mageed, Mohammed S Elballal, Mohamed Bakr Zaki, Mai A Abd-Elmawla, Tohada M Al-Noshokaty, Mahmoud A Elrebehy, Walaa A El-Dakroury, Logyna A Abulsoud, Ahmed S Doghish
Pathology, research and practice 2023 SepMerkel cell carcinoma (MCC) is an uncommon invasive form of skin cancer that typically manifests as a nodule on the face, head, or neck that is flesh-colored or bluish-red in appearance. Rapid growth and metastasis are hallmarks of MCC. MCC has the second-greatest mortality rate among skin cancers after melanoma. Despite the recent cascade of molecular investigations, no universal molecular signature has been identified as responsible for MCC's pathogenesis. The microRNAs (miRNAs) play a critical role in the post-transcriptional regulation of gene expression. Variations in the expression of these short, non-coding RNAs have been associated with various malignancies, including MCC. Although the incidence of MCC is very low, a significant amount of study has focused on the interaction of miRNAs in MCC. As such, the current survey is a speedy intensive route revealing the potential involvement of miRNAs in the pathogenesis of MCC beyond their association with survival in MCC. Copyright © 2023 Elsevier GmbH. All rights reserved.
Nehal I Rizk, Heba M Midan, Gouda Kamel Helal, Ahmed I Abulsoud, Shereen Saeid Elshaer, Ahmed A El-Husseiny, Doaa Fathi, Nourhan M Abdelmaksoud, Sherif S Abdel Mageed, Mohammed S Elballal, Mohamed Bakr Zaki, Mai A Abd-Elmawla, Tohada M Al-Noshokaty, Mahmoud A Elrebehy, Walaa A El-Dakroury, Logyna A Abulsoud, Ahmed S Doghish. The emerging role of miRNAs in Merkel cell carcinoma pathogenesis: Signaling pathway crosstalk. Pathology, research and practice. 2023 Sep;249:154771
PMID: 37611429
View Full Text